Antimicrobial polymer resins, fibers, and yarns with phosphorus content

Patent metadata

Field	Value
Publication number	US-12215225-B2
Application number	US-202217979161-A
Country	US
Kind code	B2
Filing date	Nov 2, 2022
Priority date	Jul 13, 2018
Publication date	Feb 4, 2025
Grant date	Feb 4, 2025

Abstract

The present disclosure relates to polymer resins, fibers, and yarns with permanent antimicrobial activity, and a method of producing the same. In one embodiment, the antimicrobial polymer resin comprises a polymer having less than 2500 ppm of zinc dispersed within the polymer, less than 1000 ppm of phosphorus, wherein the weight ratio of zinc to phosphorus is at least 1.3:1 or less than 0.64:1.

First claim

We claim:

1. A polyamide resin composition for molded products having permanent antimicrobial properties, the polyamide composition comprising: a polyamide selected from the group consisting of PA-4T/41, PA-4T/6I, PA-5T/5I, PA-6, PA-6,6, PA-6,6/6, PA-6,6/6T, PA-6T/61, PA-6T/61/6, PA-61T/6, PA-6T/61/66, PA-6T/MPMDT, PA-6T/66, PA-61/610, PA-10T/612, PA-10T/106, PA-61T/612, PA-61/10T, PA-61/101, PA-9T, PA-10T, PA-12T, PA-10T/101, PA-10T/12, PA-10T/11, PA-6T/9T, PA-61/12T, PA-61/10T/6I, PA-6T/61/6, PA-6T/6I/12, and combinations thereof;
molding additives comprising impact modifiers, heat stabilizers, lubricants, fillers, chain terminators, or plasticizers, or combinations thereof;
zinc dispersed within the polyamide;
less than 1000 ppm of phosphorus;
wherein the weight ratio of the zinc to the phosphorus is 2:1 to 30:1.

2. The polyamide resin composition of claim 1 , wherein the weight ratio of the zinc to the phosphorus is greater than 2:1 to less than 30:1.

3. The polyamide resin composition of claim 1 , wherein the relative viscosity of the polyamide resin composition ranges from 20 to 100.

4. The polyamide resin composition of claim 1 , wherein the polyamide resin composition comprises a delusterant including at least a portion of the phosphorus.

5. The polyamide resin composition of claim 1 , wherein the zinc is provided via a zinc compound comprising zinc oxide, zinc acetate, zinc ammonium carbonate, zinc ammonium adipate, zinc stearate, zinc phenyl phosphinic acid, zinc pyrithione and/or combinations thereof.

6. The polyamide resin composition of claim 1 , wherein the phosphorus is provided via a phosphorus compound comprising phosphoric acid, benzene phosphinic acid, benzene phosphonic acid, manganese hypophosphite, sodium hypophosphite, monosodium phosphate, hypophosphorous acid, phosphorous acid, and/or combinations thereof.

7. The polyamide resin composition of claim 1 , wherein the polyamide resin composition comprises a delusterant including at least a portion of the phosphorus, wherein molded products formed from the polyamide resin composition inhibits greater than 89% of S. aureus as measured by ISO 20743:2013.

8. The polyamide resin composition of claim 1 , wherein the polyamide comprises PA-6,6, wherein the zinc is provided via zinc oxide, wherein the weight ratio of zinc to phosphorus is greater than 2:1 and less than 30:1, wherein the polyamide resin composition inhibits greater than 95% of S. aureus as measured by ISO 20743:2013.

9. A molded product having permanent antimicrobial properties comprising: a polyamide selected from the group consisting of PA-4T/41, PA-4T/61, PA-5T/5I, PA-6, PA-6,6, PA-6,6/6, PA-6,6/6T, PA-6T/61, PA-6T/61/6, PA-61T/6, PA-6T/61/66, PA-6T/MPMDT, PA-6T/66, PA-61/610, PA-10T/612, PA-10T/106, PA-61T/612, PA-61/10T, PA-61/101, PA-9T, PA-10T, PA-12T, PA-101/101, PA-10T/12, PA-10T/11, PA-6T/9T, PA-61/12T, PA-61/10T/6I, PA-6T/61/6, PA-6T/6I/12, and combinations thereof;
molding additives comprising comprising impact modifiers, heat stabilizers, lubricants, fillers, chain terminators, or plasticizers, or combinations thereof;
zinc dispersed within the polyamide;
and less than 1000 ppm of phosphorus; wherein the weight ratio of zinc to phosphorus is 2:1 to 30:1.

10. The molded products of claim 9 , wherein the polyamide comprises a delusterant including at least a portion of the phosphorus, wherein the molded products inhibit greater than 89% of S. aureus as measured by ISO 20743:2013.

11. The molded products of claim 9 , wherein the polyamide comprises PA-6,6, wherein the zinc is provided in the form of zinc oxide and/or zinc pyrithione, and/or zinc ammonium adipate, wherein the weight ratio of zinc to phosphorus is greater than 2:1, wherein the molded products inhibit greater than 95% of S. aureus as measured by ISO 20743:2013.

12. A process for preparing molded products having permanent antimicrobial properties, the process comprising:
preparing an aqueous monomer solution;
adding zinc dispersed within the aqueous monomer solution;
adding less than 1000 ppm of phosphorus;
polymerizing the aqueous monomer solution to form a polyamide melt; and
molding the polyamide melt and molding additives to form the molded products,
wherein the molding additives comprise impact modifiers, heat stabilizers, lubricants, fillers, chain terminators, or plasticizers, or combinations thereof;
wherein the weight ratio of zinc to phosphorus is: 2:1 to 30:1;
wherein the polyamide is selected from the group consisting of PA-4T/41, PA-4T/6I, PA-51/51, PA-6, PA-6,6, PA-6,6/6, PA-6,6/6T, PA-6T/61, PA-6T/61/6, PA-61/6, PA-6T/61/66, PA-6T/MPMDT, PA-61/66, PA-61/610, PA-10T/612, PA-10T/106, PA-61/612, PA-61/10T, PA-6T/10I, PA-9T, PA-10T, PA-12T, PA-101/101, PA-10T/12, PA-10T/11, PA-61/9T, PA-61/12T, PA-61/10T/6I, PA-6T/61/6, PA-6T/6I/12, and combinations thereof.

13. The polyamide resin composition of claim 1 , wherein the molded products comprise catheters for medical purposes, prostheses, products for repairing bones, and blood transfusion bags.

14. The polyamide resin composition of claim 1 , wherein the molding additives comprise ethylene bis-stearamide, polyethylene wax, oleamide, erucamide, calcium stearate, or polytetrafluoroethylene, or combinations thereof.

15. The molded product of claim 9 , wherein the molded product comprises catheters for medical purposes, prostheses, products for repairing bones, and blood transfusion bags.

16. The molded product of claim 9 , wherein the molding additives comprise ethylene bis-stearamide, polyethylene wax, oleamide, erucamide, calcium stearate, or polytetrafluoroethylene, or combinations thereof.

17. The process of claim 12 , wherein the molded products comprise catheters for medical purposes, prostheses, products for repairing bones, and blood transfusion bags.

18. The process of claim 12 , wherein the molding additives comprise ethylene bis-stearamide, polyethylene wax, oleamide, erucamide, calcium stearate, or polytetrafluoroethylene, or combinations thereof.

Assignees

• Ascend Performance Mat Operations Llc

Inventors

• Osborn Scott E
• Yung Wai-Shing

Classifications

• D06M2101/34

  Polyamides · CPC title

• D01F9/08

  of inorganic material (working or processing of metal wire B21F; from softened glass, minerals or slags C03B37/00) · CPC title

• D01F6/90

  of polyamides · CPC title

• D01F1/103 Primary

  Agents inhibiting growth of microorganisms · CPC title

• D01D5/0023

  the material being a polymer melt · CPC title